Deckers Outdoor is up over 50% in the past year and currently trading nearly at its all-time high. Click here to read my most recent analysis of DECK stock.Read full newsRead More
Ceridian HCM reported its Q4 2022 financial results on February 9, 2023. Learn why my CDAY outlook is a Buy.Read full newsRead More
While so many investors are focusing on the banking system, I'm looking for where the next shoe will drop. Click here to read my analysis of the XLRE ETF.Read full newsRead More
Catalyst watch for the week of March 26. The hosts explore the topics Fed speakers will discuss following the FOMC meeting, earnings from MU and LULU and Blockbuster nostalgia.Read full newsRead More
Dimensional International Value ETF is slightly better than the MSCI EAFE Value Index according to various metrics. Click here for my review of the DFIV fund.Read full newsRead More
In this article, I'll be looking over Canadian Utilities. The company has long been on my watchlist. Click here to read my most recent analysis detailing why.Read full newsRead More
Saipem SpA presents long-term investment opportunity based on various persistent structural trends in the oilfield services industry. Read my analysis of SAPMF.Read full newsRead More
PepsiCo and its high-quality portfolio of brands provide shelter in tough economic environments and sequential and steady growth. Click here to read my PEP stock analysis.Read full newsRead More
Medical Properties Trust has struggled in the market in recent months, with fears about the company's prospects moving forward. Read my analysis of MPW stock.Read full newsRead More
Turmoil in the bank industry and renewed concerns of economic headwinds are driving expectations that Fed interest rate hiking is at or near an end.Read full newsRead More
Supply/demand outlook combined with relatively high yields creating attractive opportunities for natural resource investors; potential risks stemming from Russia still need to be watched.Read full newsRead More
American Shared Hospital Services (NYSE:NYSE:AMS) Q4 2022 Earnings Conference Call March 24, 2023 1:00 PM ETCompany ParticipantsStephanie Prince - PCG AdvisoryRaymond Stachowiak - Executive...Read full newsRead More
Twilio is trading at a very cheap Read full newsRead More
IDEAYA Biosciences' platform is synthetic lethality targeting cancer. The company has produced solid proof of concept data. Click here for our review of IDYA.Read full newsRead More
While many of the areas' stocks sport high valuations, Coca-Cola FEMSA has low earnings multiples and impressive growth potential. Read more about KOF here.Read full newsRead More
General Mills continues to perform exceptionally well relative to the broader equity market. Read more about GIS here.Read full newsRead More
Oxford Nanopore Technologies plc creates the technology required for studying and analyzing molecules. Find out why I recommend a buy rating for ONTTF stock.Read full newsRead More
We look at VanEck Pharmaceutical ETF when trying to get a read on the performance of the large-cap pharmaceutical industry. Read my analysis of PPH ETF.Read full newsRead More
In his Berkshire Hathaway letter, Warren Buffett wrote, "At Berkshire, there will be no finish line.Read full newsRead More
Impel Pharmaceuticals Inc. (NASDAQ:NASDAQ:IMPL) Q4 2022 Earnings Conference Call March 24, 2023 8:30 AM ETCompany ParticipantsAdrian Adams - Chairman & Chief Executive OfficerLeonard...Read full newsRead More